💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for CASI Pharmaceuticals, Inc. (CASI)
« Back to company indexCASI Chatter Timeline
Stock Ticker for CASI
Most Active Tweeters for CASI
| User | Tweets |
|---|---|
| @Tickeron | 17 |
| @PennySearch | 6 |
| @SendItTrading | 5 |
| @ItzHindsight | 4 |
| @stockwatch02 | 4 |
Recent Tweets for CASI
 |
@volcomboy469 @ItzHindsight @T_OConnell The most broken stock I have ever seen $casi January 25th 2022, 10:01pm |
 |
@ItzHindsight @T_OConnell Any thoughts on $CASI January 25th 2022, 9:01pm |
 |
@Tickeron $CASI enters a Downtrend because Momentum Indicator dropped below the 0 level on January 3, 2022. View odds for thi… https://t.co/Uz88ZUkfdl January 25th 2022, 5:01pm |
|
@Tickeron Wow this is a big change! $CASI Aroon Indicator entered a Downtrend. #CASIPharmaceuticals #stockmarket #stock… https://t.co/aJktIv5nm6 January 25th 2022, 4:01pm |
 |
@invescent $CASI Data indicates that the overall analyst sentiment for CASI is bearish. Simplify the way you research stock… https://t.co/GKKSJS6hh2 January 25th 2022, 4:01pm |
 |
@stockwatch02 RT @ACInvestorBlog: $CASI looks strong (penny play) January 25th 2022, 3:01pm |
 |
@ACInvestorBlog $CASI looks strong (penny play) January 25th 2022, 3:01pm |
 |
@PennySearch $CASI BTIG gave CASI a Buy stock rating on 2021-05-18. Find top penny stocks with PennySearch before the moon la… https://t.co/UTHOjgbGNN January 25th 2022, 10:01am |
|
@Tickeron $CASI's Aroon indicator drops into Downtrend on January 21, 2022. View odds for this and other indicators:… https://t.co/4xU9DUk0Ue January 25th 2022, 12:01am |
 |
@SendItTrading $CASI Lower than average short interest today and Friday. Looks like a lot of the selling was dumb retail selling a… https://t.co/ztWuxYaNJG January 24th 2022, 11:01pm |
|
@PennySearch $CASI BTIG gave CASI a Buy stock rating on 2021-05-18. Find top penny stocks with PennySearch before the moon la… https://t.co/Ad8HsLAur7 January 24th 2022, 9:01am |
 |
@ShortAlgoKing $CASI Watching for Buy Signal. Chart by https://t.co/qchl9O5K2n https://t.co/ZEfaocmTM0 January 23rd 2022, 12:01pm |
|
@SendItTrading @gurgavin $CASI Ceo owns 27 million shares with average around $2 a share. Just announced a 10 million share buyback. Solid pipeline. January 23rd 2022, 12:01am |
|
@Tickeron $CASI's Aroon indicator drops into Downtrend on January 21, 2022. View odds for this and other indicators:… https://t.co/SsseImXkkn January 22nd 2022, 11:01am |
|
@Tickeron How does this make you feel? $CASI Aroon Indicator entered a Downtrend. #CASIPharmaceuticals #stockmarket #stock… https://t.co/oasUlcKsZH January 22nd 2022, 11:01am |
 |
@23Bjorn02 $casi so CHEAP!!!! Unbelievable. Ceo of casi has to want to buy so much more. This casi will be a big hit. Watch..mark this post $casi January 22nd 2022, 1:01am |
|
@Tickeron $CASI enters a Downtrend as Momentum Indicator dropped below the 0 level on January 3, 2022. View odds for this and… https://t.co/btyFIAM32S January 22nd 2022, 12:01am |
|
@Tickeron Does this make you nervous? $CASI RSI Indicator left the oversold zone. #CASIPharmaceuticals #stockmarket #stock… https://t.co/zHI2Gx0ElL January 21st 2022, 11:01pm |
 |
@pytweetUM RT @JustAGu06944949: If $XELA insiders don’t make any significant purchases, or they don’t announce a share buyback program like $CASI, thi… January 21st 2022, 11:01pm |
 |
@JustAGu06944949 If $XELA insiders don’t make any significant purchases, or they don’t announce a share buyback program like $CASI,… https://t.co/EAnNkpioIS January 21st 2022, 11:01pm |
|
@Tickeron What do you think of this? $CASI Aroon Indicator entered a Downtrend. #CASIPharmaceuticals #stockmarket #stock… https://t.co/MPqQqpUyep January 21st 2022, 11:01pm |
 |
@Gambiste1 RT @ItzHindsight: Dips are your friend for long term holders. $COIN $CASI #CLOV January 21st 2022, 5:01pm |
|
@ItzHindsight Dips are your friend for long term holders. $COIN $CASI #CLOV January 21st 2022, 5:01pm |
 |
@ShortAlgoTrades $CASI Awaiting Buy Signal. Chart by https://t.co/jpmUt7BvVp https://t.co/IG70nkh506 January 21st 2022, 1:01pm |
 |
@GetOnTrade $CASI Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag https://t.co/ee6zotYNHU January 20th 2022, 9:01pm |
|
@Tickeron $CASI enters a Downtrend because Momentum Indicator dropped below the 0 level on January 3, 2022. View odds for thi… https://t.co/A6IHdbpLrr January 20th 2022, 9:01pm |
|
@JustAGu06944949 Still buying these $CASI dips. Good PR today & they’re buying back shares. Enough for me. January 20th 2022, 7:01pm |
|
@Tickeron Is this good for your portfolio? $CASI RSI Indicator left the oversold zone. #CASIPharmaceuticals #stockmarket… https://t.co/T4tZRA2UMm January 20th 2022, 6:01pm |
 |
@sparrowinvests RT @ACInvestorBlog: $CASI HUGE News !! January 20th 2022, 5:01pm |
 |
@willyraw77 RT @MarketCurrents: $CASI - CASI announces FDA’s Orphan Drug Designation for follicular lymphoma candidate https://t.co/2UnI1R34bf January 20th 2022, 5:01pm |
|
@willyraw77 RT @iamdlsamuels: $CASI keeps popping up. Needs the volume to start run. January 20th 2022, 5:01pm |
|
@willyraw77 RT @TopStockAlerts1: $CASI keep an eye on it for continuation! January 20th 2022, 5:01pm |
|
@PennySearch $CASI BTIG gave CASI a Buy stock rating on 2021-05-18. Find top penny stocks with PennySearch before the moon la… https://t.co/virmu3cl0Y January 20th 2022, 5:01pm |
 |
@jannik_reiners $CASI CASI Pharmaceuticals Partner, BioInvent, Announces BI -1206 Granted Orphan Drug Designation By The U.S. FDA F… https://t.co/2F7t413wSu January 20th 2022, 4:01pm |
 |
@EW09086218 RT @ZoZoStockwatch: $CASI CASI PHARMACEUTICALS PARTNER, BIOINVENT, ANNOUNCES BI -1206 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA FOR T… January 20th 2022, 3:01pm |
|
@Gambiste1 RT @ItzHindsight: $CASI gonna run when we least expect it. January 20th 2022, 3:01pm |
 |
@69NiceBot69 RT @singlesdoubles: $CASI will take a shot here. Long just over .69 January 20th 2022, 3:01pm |
 |
@singlesdoubles $CASI will take a shot here. Long just over .69 January 20th 2022, 3:01pm |
|
@ItzHindsight $CASI gonna run when we least expect it. January 20th 2022, 3:01pm |
 |
@hesham_monica $CASI Awaiting Buy Signal. Free Trial https://t.co/wUyihf7O6A https://t.co/F3S3BKjovt January 20th 2022, 2:01pm |
|
@JustAGu06944949 $CASI volume already surpassing the daily average 4 minutes after market opening! #CASI January 20th 2022, 2:01pm |
 |
@DonnyJohnson24 Swinging $CASI January 20th 2022, 2:01pm |
 |
@art_isit $CASI -the fDA has granted Orphan Drug Designation to BioInvent International AB's (OTC: BOVNF) BI-1206, an anti-Fc… https://t.co/53Xn4MrEk8 January 20th 2022, 2:01pm |
|
@JustAGu06944949 This is how you know a stock is undervalued. $CASI news from 12-17-2021. When a stock has an offering at lows, ti… https://t.co/OlllyUZHuw January 20th 2022, 2:01pm |
 |
@stockwatchsthlm RT @stock_titan: $CASI CASI PHARMACEUTICALS PARTNER, BIOINVENT, ANNOUNCES BI -1206 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA FOR THE… January 20th 2022, 1:01pm |
 |
@ama_insomnio $CASI- GOOD NEWS ? https://t.co/ea9ivAYZ1M January 20th 2022, 1:01pm |
 |
@OpenOutcrier $CASI (+5.8% pre) CASI PHARMACEUTICALS PARTNER, BIOINVENT, ANNOUNCES BI -1206 GRANTED ORPHAN DRUG DESIGNATION BY TH… https://t.co/jmCpr0fOXU January 20th 2022, 1:01pm |
 |
@nicoleneverchas $CASI-CASI Pharmaceuticals Partner, BioInvent, Announces BI -1206 Has Been Granted Orphan Drug Designation By The U… https://t.co/0GW8EG1Bh3 January 20th 2022, 1:01pm |
 |
@MarketCurrents $CASI - CASI announces FDA’s Orphan Drug Designation for follicular lymphoma candidate https://t.co/2UnI1R34bf January 20th 2022, 1:01pm |
 |
@iamdlsamuels $CASI keeps popping up. Needs the volume to start run. January 20th 2022, 12:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?